LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines
Michela Coan,Martina Toso,Laura Cesaratto,Ilenia Rigo,Silvia Borgna,Anna Dalla Pietà,Luigi Zandonà,Lorenzo Iuri,Antonella Zucchetto,Carla Piazza,Gustavo Baldassarre,Riccardo Spizzo,Milena Sabrina Nicoloso,Anna Dalla PietÃ,Luigi ZandonÃ
DOI: https://doi.org/10.3390/ijms241813736
IF: 5.6
2023-09-06
International Journal of Molecular Sciences
Abstract:TP53 is the most frequently mutated gene in human cancers. Most TP53 genomic alterations are missense mutations, which cause a loss of its tumour suppressor functions while providing mutant p53 (mut_p53) with oncogenic features (gain-of-function). Loss of p53 tumour suppressor functions alters the transcription of both protein-coding and non-protein-coding genes. Gain-of-function of mut_p53 triggers modification in gene expression as well; however, the impact of mut_p53 on the transcription of the non-protein-coding genes and whether these non-protein-coding genes affect oncogenic properties of cancer cell lines are not fully explored. In this study, we suggested that LINC01605 (also known as lincDUSP) is a long non-coding RNA regulated by mut_p53 and proved that mut_p53 directly regulates LINC01605 by binding to an enhancer region downstream of the LINC01605 locus. We also showed that the loss or downregulation of LINC01605 impairs cell migration in a breast cancer cell line. Eventually, by performing a combined analysis of RNA-seq data generated in mut_TP53-silenced and LINC01605 knockout cells, we showed that LINC01605 and mut_p53 share common gene pathways. Overall, our findings underline the importance of ncRNAs in the mut_p53 network in breast and ovarian cancer cell lines and in particular the importance of LINC01605 in mut_p53 pro-migratory pathways.
biochemistry & molecular biology,chemistry, multidisciplinary